{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:00:49Z","timestamp":1773486049970,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.clon.2006.11.008","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T07:24:59Z","timestamp":1165994699000},"page":"150-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["13-cis-Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer \u2014 Report of a Pilot Phase II Study"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Michael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Maraveyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lofts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2006.11.008_bib1","series-title":"CancerStats monograph","author":"Toms","year":"2004"},{"key":"10.1016\/j.clon.2006.11.008_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.11.008_bib3","first-page":"1453","article-title":"Cancer combination chemotherapy with retinoids: experimental rationale","volume":"8","author":"Bollag","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.clon.2006.11.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcb.240590802","article-title":"Retinoids and chemoprevention: clinical and basic studies","volume":"22","author":"Lippman","year":"1995","journal-title":"J Cell Biochem Suppl"},{"key":"10.1016\/j.clon.2006.11.008_bib5","first-page":"2415","article-title":"Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers","volume":"16","author":"Lotan","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2006.11.008_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cdd.4400337","article-title":"Retinoid-induced apoptosis in normal and neoplastic tissues","volume":"5","author":"Nagy","year":"1998","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.clon.2006.11.008_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.clon.2006.11.008_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0092-8674(92)90479-V","article-title":"9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor","volume":"68","author":"Heyman","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.clon.2006.11.008_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bjc.6600496","article-title":"Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2\/Bax","volume":"87","author":"Pettersson","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2006.11.008_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/carcin\/bgh122","article-title":"Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid","volume":"25","author":"Balasubramanian","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.clon.2006.11.008_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4161\/cbt.4.5.1762","article-title":"High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro","volume":"4","author":"El-Metwally","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clon.2006.11.008_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/cbt.4.4.1701","article-title":"Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant","volume":"4","author":"El-Metwally","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clon.2006.11.008_bib13","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/sj.onc.1208586","article-title":"A novel retinoid-related molecule inhibits pancreatic cancer cell proliferation by a retinoid receptor independent mechanism via suppression of cell cycle regulatory protein function and induction of caspase-associated apoptosis","volume":"24","author":"Balasubramanian","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.clon.2006.11.008_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00006676-200110000-00008","article-title":"Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells","volume":"23","author":"Pettersson","year":"2001","journal-title":"Pancreas"},{"key":"10.1016\/j.clon.2006.11.008_bib15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2317::AID-CNCR11>3.0.CO;2-P","article-title":"A phase II pilot trial of 13-cis retinoic acid and interferon-alpha in patients with advanced pancreatic carcinoma","volume":"83","author":"Brembeck","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2006.11.008_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clon.2006.11.008_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/35106036","article-title":"The promise of retinoids to fight against cancer","volume":"1","author":"Altucci","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clon.2006.11.008_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198612113152401","article-title":"13-cis-Retinoic acid in the treatment of oral leukoplakia","volume":"315","author":"Hong","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2006.11.008_bib19","first-page":"1555","article-title":"Redifferentiation therapy with retinoic acid in follicular thyroid cancer","volume":"39","author":"Grunwald","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clon.2006.11.008_bib20","first-page":"838","article-title":"The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer","volume":"6","author":"Kelly","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2006.11.008_bib21","first-page":"541","article-title":"Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma","volume":"20","author":"Somos","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2006.11.008_bib22","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2001.19.10.2754","article-title":"Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations","volume":"19","author":"Lawrence","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.11.008_bib23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1023\/A:1026579400806","article-title":"A phase I\u2013II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study","volume":"11","author":"Miller","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2006.11.008_bib24","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1200\/JCO.2000.18.16.2972","article-title":"Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma","volume":"18","author":"Motzer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2006.11.008_bib25","first-page":"287","article-title":"Phase I trial of 9-cis retinoic acid in adults with solid tumors","volume":"2","author":"Kurie","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2006.11.008_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1346-8138.1992.tb03766.x","article-title":"Chemoprevention of skin cancer in xeroderma pigmentosum","volume":"19","author":"Kraemer","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.clon.2006.11.008_bib27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","article-title":"Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin","volume":"318","author":"Kraemer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2006.11.008_bib28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","article-title":"Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group","volume":"341","author":"Matthay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2006.11.008_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/93.8.605","article-title":"Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer","volume":"93","author":"Lippman","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clon.2006.11.008_bib30","first-page":"35","article-title":"Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study","volume":"19","author":"Park","year":"1998","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506004225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655506004225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:31:00Z","timestamp":1760542260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655506004225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0936655506004225"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2006.11.008","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"13-cis-Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer \u2014 Report of a Pilot Phase II Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2006.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}